Annual report
4530.TEDINET S100VT69
Period2024-03-01 → 2025-02-28
Filed2025-05-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥156.0bn | 2024-03-01 → 2025-02-28 | Cons. | Net sales |
| Revenue | ¥141.7bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥128.3bn | 2022-03-01 → 2023-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥120.2bn | 2021-03-01 → 2022-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥114.5bn | 2020-03-01 → 2021-02-28d | Cons. | Net sales (5-year summary) |
| Operating income | ¥18.9bn | 2024-03-01 → 2025-02-28 | Cons. | Operating income |
| Operating income | ¥13.2bn | 2023-03-01 → 2024-02-29 | Cons. | Operating income |
| Ordinary income | ¥24.0bn | 2024-03-01 → 2025-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥19.6bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥16.1bn | 2022-03-01 → 2023-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.6bn | 2021-03-01 → 2022-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.8bn | 2020-03-01 → 2021-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥28.7bn | 2024-03-01 → 2025-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥19.2bn | 2023-03-01 → 2024-02-29 | Cons. | Income before income taxes |
| Net income (owners) | ¥21.8bn | 2024-03-01 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥14.0bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.7bn | 2022-03-01 → 2023-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.7bn | 2021-03-01 → 2022-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.3bn | 2020-03-01 → 2021-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥22.3bn | 2024-03-01 → 2025-02-28 | Cons. | Profit loss |
| Net income | ¥14.4bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss |
| Total assets | ¥343.1bn | at 2025-02-28 | Cons. | Assets |
| Total assets | ¥328.8bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥313.9bn | at 2023-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥302.9bn | at 2022-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥299.9bn | at 2021-02-28d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥63.7bn | at 2025-02-28 | Cons. | Liabilities |
| Total liabilities | ¥61.7bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥279.4bn | at 2025-02-28 | Cons. | Net assets |
| Net assets / equity | ¥267.1bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥258.4bn | at 2023-02-28d | Cons. | Net assets |
| Net assets / equity | ¥254.9bn | at 2022-02-28d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥253.8bn | at 2021-02-28d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥114.5bn | at 2025-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥112.5bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash & equivalents | ¥89.8bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥66.4bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥65.4bn | at 2023-02-28d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.2bn | at 2022-02-28d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥91.4bn | at 2021-02-28d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥18.8bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥18.2bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥12.7bn | 2022-03-01 → 2023-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥19.2bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.3bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥17.6bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥23.9bn | 2022-03-01 → 2023-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.1bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥7.8bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥15.8bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥16.7bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥14.7bn | 2022-03-01 → 2023-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥15.2bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.2bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥295.57 | 2024-03-01 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.62 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.01 | 2022-03-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥118.92 | 2021-03-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.22 | 2020-03-01 → 2021-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥295.15 | 2024-03-01 → 2025-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥181.42 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.88 | 2022-03-01 → 2023-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥118.84 | 2021-03-01 → 2022-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥113.11 | 2020-03-01 → 2021-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥3,788.47 | at 2025-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,492.62 | at 2024-02-29 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,294.2 | at 2023-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,171.83 | at 2022-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,083.98 | at 2021-02-28d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 80.6% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.6% | at 2023-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.5% | at 2022-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.1% | at 2021-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.0% | 2024-03-01 → 2025-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2023-03-01 → 2024-02-29 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2022-03-01 → 2023-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-03-01 → 2022-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2020-03-01 → 2021-02-28d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,799 | at 2025-02-28 | Cons. | Number of employees |
| Employees | 2,759 | at 2024-02-29 | Cons. | Number of employees |
| Employees | 2,769 | at 2023-02-28d | Cons. | Number of employees |
| Employees | 2,784 | at 2022-02-28d | Cons. | Number of employees |
| Employees | 2,770 | at 2021-02-28d | Cons. | Number of employees |
| Revenue | ¥102.6bn | 2024-03-01 → 2025-02-28 | Standalone | Net sales |
| Revenue | ¥96.6bn | 2023-03-01 → 2024-02-29 | Standalone | Net sales |
| Revenue | ¥93.0bn | 2022-03-01 → 2023-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥90.6bn | 2021-03-01 → 2022-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥86.7bn | 2020-03-01 → 2021-02-28d | Standalone | Net sales (5-year summary) |
| Operating income | ¥13.7bn | 2024-03-01 → 2025-02-28 | Standalone | Operating income |
| Operating income | ¥10.7bn | 2023-03-01 → 2024-02-29 | Standalone | Operating income |
| Ordinary income | ¥16.5bn | 2024-03-01 → 2025-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥14.2bn | 2023-03-01 → 2024-02-29 | Standalone | Ordinary income |
| Ordinary income | ¥14.1bn | 2022-03-01 → 2023-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.6bn | 2021-03-01 → 2022-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.4bn | 2020-03-01 → 2021-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥21.2bn | 2024-03-01 → 2025-02-28 | Standalone | Income before income taxes |
| Profit before tax | ¥13.8bn | 2023-03-01 → 2024-02-29 | Standalone | Income before income taxes |
| Net income | ¥16.4bn | 2024-03-01 → 2025-02-28 | Standalone | Profit loss |
| Net income | ¥9.9bn | 2023-03-01 → 2024-02-29 | Standalone | Profit loss |
| Net income | ¥10.4bn | 2022-03-01 → 2023-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.2bn | 2021-03-01 → 2022-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.3bn | 2020-03-01 → 2021-02-28d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥249.2bn | at 2025-02-28 | Standalone | Assets |
| Total assets | ¥256.0bn | at 2024-02-29 | Standalone | Assets |
| Total assets | ¥254.0bn | at 2023-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥254.3bn | at 2022-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥264.1bn | at 2021-02-28d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥40.6bn | at 2025-02-28 | Standalone | Liabilities |
| Total liabilities | ¥43.2bn | at 2024-02-29 | Standalone | Liabilities |
| Net assets / equity | ¥208.6bn | at 2025-02-28 | Standalone | Net assets |
| Net assets / equity | ¥212.8bn | at 2024-02-29 | Standalone | Net assets |
| Net assets / equity | ¥214.5bn | at 2023-02-28d | Standalone | Net assets |
| Net assets / equity | ¥222.4bn | at 2022-02-28d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥231.2bn | at 2021-02-28d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥43.3bn | at 2025-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥52.0bn | at 2024-02-29 | Standalone | Cash and deposits |
| EPS (basic) | ¥222.2 | 2024-03-01 → 2025-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.08 | 2023-03-01 → 2024-02-29 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥131.21 | 2022-03-01 → 2023-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.25 | 2021-03-01 → 2022-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.07 | 2020-03-01 → 2021-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥221.88 | 2024-03-01 → 2025-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥127.93 | 2023-03-01 → 2024-02-29 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥131.1 | 2022-03-01 → 2023-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥88.19 | 2021-03-01 → 2022-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.97 | 2020-03-01 → 2021-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥90 | 2024-03-01 → 2025-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2023-03-01 → 2024-02-29 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥84.5 | 2022-03-01 → 2023-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥84 | 2021-03-01 → 2022-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥83.5 | 2020-03-01 → 2021-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,852.47 | at 2025-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,804.37 | at 2024-02-29 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,754.67 | at 2023-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,784.39 | at 2022-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,825.43 | at 2021-02-28d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.5% | at 2025-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.0% | at 2024-02-29 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.3% | at 2023-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.3% | at 2022-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.8% | 2024-03-01 → 2025-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.6% | 2023-03-01 → 2024-02-29 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.8% | 2022-03-01 → 2023-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.2% | 2021-03-01 → 2022-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2020-03-01 → 2021-02-28d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 85,164,895 | at 2025-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2024-02-29 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2023-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2022-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2021-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,488 | at 2025-02-28 | Standalone | Number of employees |
| Employees | 1,506 | at 2024-02-29 | Standalone | Number of employees |
| Employees | 1,521 | at 2023-02-28d | Standalone | Number of employees |
| Employees | 1,587 | at 2022-02-28d | Standalone | Number of employees |
| Employees | 1,583 | at 2021-02-28d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-02-28 | 58 pure |
| Pharmaceutical Businessreportable segment | employees | at 2025-02-28 | 2741 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,022
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 73249400 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 47595 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 85164895 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 732494 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 11792500 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 11792500 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.1385 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row2Member | 23000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row2Member | 52400 | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row2Member | 75400 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row2Member | 0.0009 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 11815500 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | 52400 | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 11867900 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.1394 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 3301000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 45.00 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 3301000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 45.00 | |
| Number of male directors and other officers | FilingDateInstant | 12 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.143 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000NakatomiKazuhideMember | 248000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000SaitoKyuMember | 7000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000TsutsumiNobuoMember | 5000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000MurayamaShinichiMember | 6000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000TakiyamaKojiMember | 3000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000IsobeYuichiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000AnzaiYuichiroMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000MatsuoTetsugoMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000WatanabeTamakoMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000NoguchiMidoriMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000NakatomiNobuyukiMember | 227000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000HiranoMunehikoMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000WatanabeKentaroMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00944-000ItakuraRyusukeMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 500000 | |
| Audit fees reporting company | Prior1YearDuration | 53000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | 16000000 | JPY |
| Audit fees reporting company | CurrentYearDuration | 53000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | 3000000 | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | 2000000 | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | 3000000 | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | 2000000 | JPY |
| Audit fees total | Prior1YearDuration | 56000000 | JPY |
| Non audit fees total | Prior1YearDuration | 18000000 | JPY |
| Audit fees total | CurrentYearDuration | 56000000 | JPY |
| Non audit fees total | CurrentYearDuration | 2000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |